Back
abrdn Life Sciences Investors Vs. Corbus Pharmaceuticals Holdings Industry Stock Comparison
Buy
58
HQL
abrdn Life Sciences Investors
Last Price:
14.07
Seasonality Move:
-1.02%
Sell
49
CRBP
Corbus Pharmaceuticals Holdings
Last Price:
44.10
Seasonality Move:
-11.02%
Buy
58
abrdn Life Sciences Investors (HQL)
is a Buy
Is abrdn Life Sciences Investors a Buy, Sell or Hold?
- The current abrdn Life Sciences Investors [HQL] share price is $14.19. The Score for HQL is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- HQL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
Corbus Pharmaceuticals Holdings (CRBP)
is a Sell
Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?
- The current Corbus Pharmaceuticals Holdings [CRBP] share price is $44.30. The Score for CRBP is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- CRBP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HQL Stock Price Chart
What is abrdn Life Sciences Investors's stock price today?
-
The abrdn Life Sciences Investors share price today is $14.19
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HQL is experiencing slight selling pressure.
CRBP Stock Price Chart
What is Corbus Pharmaceuticals Holdings's stock price today?
-
The Corbus Pharmaceuticals Holdings share price today is $44.30
The current trend is moderately bearish and CRBP is experiencing slight selling pressure.
HQL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 66.42 | Buy |
| Chaikin Money Flow: | -15441 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.38 - 13.98) | Buy |
| Bollinger Bands (100): | (13.24 - 13.98) | Buy |
CRBP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.34 | Buy |
| Relative Strength Index (14 RSI): | 49.14 | Sell |
| Chaikin Money Flow: | -68505 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.41 - 48.51) | Sell |
| Bollinger Bands (100): | (30.43 - 45.69) | Buy |
HQL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.87 | Buy |
| 20-day SMA: | 13.67 | Buy |
| 50-day SMA: | 13.55 | Buy |
| 200-day SMA: | 13.15 | Buy |
| 8-day EMA: | 13.91 | Buy |
| 20-day EMA: | 13.78 | Buy |
| 50-day EMA: | 13.65 | Buy |
| 200-day EMA: | 13.48 | Buy |
CRBP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 45.47 | Sell |
| 20-day SMA: | 45.57 | Sell |
| 50-day SMA: | 42.55 | Buy |
| 200-day SMA: | 22.33 | Buy |
| 8-day EMA: | 44.69 | Sell |
| 20-day EMA: | 45.06 | Sell |
| 50-day EMA: | 42.58 | Buy |
| 200-day EMA: | 27.79 | Buy |
abrdn Life Sciences Investors Earnings Growth & HQL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.55 per share, an increase next quarter of $0.28 per share, an increase this year of $5.53 per share, and an increase next year of $0.35 per share.
abrdn Life Sciences Investors Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corbus Pharmaceuticals Holdings Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||